Stock J90 NUREXONE BIOLOGIC INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights NurExone Biologic Inc. Deutsche Boerse AG

Equities

J90

CA67059R1091

Real-time Estimate Tradegate
Other stock markets
 11:29:08 2024-07-04 EDT 		5-day change 1st Jan Change
0.469 EUR +4.22% Intraday chart for NurExone Biologic Inc. -4.74% +158.48%
05-29 NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 NurExone Biologic Announces OTCQB Listing And DTC Eligibility MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NurExone Biologic Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
NurExone Biologic Announces OTCQB Listing And DTC Eligibility
MT
NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NurExone Biologic Building a Research and Development Facility in Israel
MT
NurExone Biologic Inc. Establishes Research and Development Facility in Haifa, Israel
CI
NurExone Biologic Inc. Expands Intellectual Property Portfolio
CI
NurExone Biologic Inc. Launches Licensing Efforts for ExoTherapy Platform
CI
NurExone Biologic Provides Operations Update
MT
NurExone Biologic Posts Q1 Net Loss
MT
NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, For Acute Spinal Cord Injuries Treatmenet
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRX Stock
  4. J90 Stock
  5. News NurExone Biologic Inc.
  6. Highlights